Design and synthesis of new nanobiomaterials with antimicrobial properties

18 July 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

In this work, new nanostructured copper materials have been designed, synthetized and evaluated in order to produce a more efficient and sustainable copper bionanohybrid with catalytical and antimicrobial properties. Thus, conditions are sought where the most critical steps are reduced or minimized, such as the use of reducing agents or the cryogenization step. In addition, the new materials have been characterized through different techniques and their oxidative and reductive capacity has been evaluated, as well as their antimicrobial activity. We demonstrate that the addition of different quantities of reducing agent in the synthesis method generates copper bionanohybrids with different metallic species, nanoparticles sizes and morphologies (spherical, nanorod, nanowires structures) , and antimicrobial activity. The antimicrobial properties of the bionanohybrids were studied against two different strain of bacteria, Escherichia coli and Bacillus subtilis, through two different methods: by counting the CFU and via disk diffusion test, respectively. In both cases, Cu-PHOS-100%R, with the highest percentage of reducing agent, was the most efficient, achieving a MIC value against B. subtilis of 125 µg/mL and an E. coli percentage reduction of 95% in 4h. Notable results were also obtained with the bionanohybrids with lowest reduction percentages, such as Cu-PHOS-10%R, which showed a MIC of 250 µg/mL and a bacteria reduction of 82%.

Keywords

copper
nanoparticles
nanostructured materials
metal bionanohybrids
antimicrobial activity.

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.